Recall Record

Jacksonville, FL, United States

Medtronic Xomed, Inc. recalls

12 recalls recorded since 2018, most recently on 17 July 2025. 10 are listed as ongoing. Status and classification are as published by the FDA.

Recalls12
Ongoing (FDA)10
Terminated or completed2
Class I (FDA)2

Ongoing Class II Medical devices

Recall started
17 July 2025
Reason
Due to out of the box wobble of the driver.
Distribution
U.S.: AZ, CA, CO, CT, FL, GA, IA, IL, IN, LA, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OR, SC, TN, TX, O.U.S.: Canada, China, Croatia, France, Germany, India, Italy, Japan, Jordan, Kuwait, Norway, Romania, South Korea, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom
Initiated
Voluntary: Firm initiated
Recall number
Z-2461-2025

Ongoing Class II Medical devices

Recall started
10 March 2025
Reason
Nerve Monitoring System with certain software versions has potential for increased stimulus artifact, which may require troubleshooting, and may lead to procedure delay, extubation, and medical intervention.
Distribution
Worldwide - US Nationwide distribution including in the states of MD, MN, PA, OK, OH, FL, CO, GA, NC, KS, IL, WY, AK, NE, VA, MI, CA, NY, WI, UT, AZ, AR, TX, WA, AL, NJ, SD, MS, KY, TN, MO, OR, MT, MA, CT, NM, LA, WV, NH, DC, DE, IN, NV, IA, SC, ID, ME, HI, RI, VT, ND, GU, PR and the countries of Al
Initiated
Voluntary: Firm initiated
Recall number
Z-1623-2025

Ongoing Class II Medical devices

Recall started
5 July 2024
Reason
Product was distributed past expiration date.
Distribution
International distribution to the country of Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-3130-2024

Ongoing Class I Medical devices

Recall started
24 June 2024
Reason
Potential for false negative response on the NIM Vital Nerve Monitoring System
Distribution
Worldwide distribution - US Nationwide and the countries of Algeria, Argentina, Armenia, Australia, Austria, Bahrain, Belgium, Bulgaria, Canada, Canary Islands, Cayman Islands, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Egypt, El Salvador, Finla
Initiated
Voluntary: Firm initiated
Recall number
Z-2409-2024

Ongoing Class II Medical devices

Recall started
7 November 2023
Reason
Firm received reports of customers experiencing noise from the NIM System, lead-off or high impedance issues, or loss of/intermittent nerve monitoring,
Distribution
Worldwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0696-2024

Ongoing Class II Medical devices

Recall started
3 May 2022
Reason
Software anomaly was identified.
Distribution
Worldwide distribution - US Nationwide distribution in the states of TX, CO, NJ and the country of France.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1224-2022, Z-1223-2022

Ongoing Class I Medical devices

Recall started
29 April 2022
Reason
The firm received reports of events related to airway obstruction while using NIM Standard Reinforced EMG Endotracheal Tubes & NIM CONTACT Reinforced EMG Endotracheal Tubes.
Distribution
Worldwide distribution: US (nationwide) and OUS (foreign) countries of: Algeria, Argentina, Australia, Austria, Belgium, Brazil, Canada, Canary Islands, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, French Guiana, Germany, Greece, Hong Kong, Hungary, Iceland, Ind
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1520-2022, Z-1519-2022, Z-1521-2022

Ongoing Class II Medical devices

Recall started
22 December 2021
Reason
There is potential for multiple issues due to a manufacturing nonconformity.
Distribution
Worldwide distribution - US Nationwide and the countries of Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Canada, Canary Islands, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Faroe Islands, Finland, France, French G
Initiated
Voluntary: Firm initiated
Recall number
Z-0743-2022

Terminated Class II Medical devices

Recall started
15 December 2021
Terminated
9 June 2023
Reason
As a result of Medtronic's integrated power console (authentication number: 222ACBZX00018000) being used with software version: v2.7.3.0, it was discovered that there was a defect that resulted in a difference between the set number of rotations and the actual number of rotations in a specific mode when the product was used with our company's M5 handpiece.
Distribution
International distribution country of Japan.
Initiated
Voluntary: Firm initiated
Recall number
Z-0961-2022

Ongoing Class II Medical devices

Recall started
31 August 2021
Reason
There was an increase in complaints related to tip breaks and wobble/vibration.
Distribution
Worldwide distribution - US Nationwide, including PR. There was also government/military distribution and the countries of Australia, Austria, Bahrain, Belgium, Canada, Chile, Croatia, Czech Republic, Denmark, Dominican Republic, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Icela
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0158-2022, Z-0157-2022, Z-0156-2022

Terminated Class II Medical devices

Recall started
12 June 2020
Terminated
20 April 2023
Reason
During internal testing execution of the next generation of Integrated Power Console (IPC) prototype it was noted that the M5 Microdebrider was rotating at a higher speed than the set value in the cosole.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, AK, AZ, AR, CA,CO, CT, FL, GA, HI, ID,IL, IN, IA, KS, KY, LA, MD, MA, MI, MN, MS, MO, NE, NV, NH, NJ, NY, NC, OH, OK, PA, RI, SC, TN, TX, UT, VA, WV, WA, WI. The countries of Australia, Austria, Belgium, Canada, Chin
Initiated
Voluntary: Firm initiated
Recall number
Z-2673-2020

Ongoing Class II Medical devices

Recall started
13 November 2019
Reason
Routine sterilization dose does not meet the required Sterility Assurance Level.
Distribution
Affected product was only distributed in Japan.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0735-2020, Z-0734-2020, Z-0733-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.